New diabetes clinical trial: Health Improvements by Understanding the Determinants of Residual Risk in Coronary Artery Disease and New Targets for Prevention and Treatment
Published on: September 18, 2024 at 11:00PM
Conditions: Coronary Arterial Disease (CAD)
Interventions: Diagnostic Test: Cardiac CT
Sponsors: Fondazione Toscana Gabriele Monasterio; CNR Institute of Clinical Physiology, Pisa, Italy; IRCCS SYNLAB SDN, Naples, Italy
Recruiting
https://ift.tt/gNmRoFb
Conditions: Coronary Arterial Disease (CAD)
Interventions: Diagnostic Test: Cardiac CT
Sponsors: Fondazione Toscana Gabriele Monasterio; CNR Institute of Clinical Physiology, Pisa, Italy; IRCCS SYNLAB SDN, Naples, Italy
Recruiting
https://ift.tt/gNmRoFb
Comments
Post a Comment